hua33
mAbexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2004 (NCT00199797)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cell surface A33 antigenBINDING AGENT
GPA33 binding agent
- Tumor antigensImmunity, passive
Tumor antigens immunity, passive
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109671 ↗
- ChEMBLCHEMBL2109435 ↗
Also known as
- hua33
- hua33
- hua33 (131i)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00199797 | Phase 1 | Oct 1, 2004 | J. W. Goethe University, Ludwig Institute for Cancer Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| J. W. Goethe University | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Ludwig Institute for Cancer Research | Academic/Hospital | 1 | 1 | 1 | 2004 |
2 organizations
Page 1 / 1